aXichem exhibits at Vitafoods Europe 2021 in Geneva, and launches a new website presenting the unique product aXivite
aXichem AB (publ), a developer of natural analogue industrial compounds, is participating in Vitafoods Europe 2021, 5–7 October, in Geneva. With the event aXichem launches a new website, axivite.com, to support the marketing of its unique phenylcapsaicin product, aXivite. Meet aXichem in person at booth # K264, or at the on-line event, on 4–8 October, at this hybrid version of Vitafoods Europe.
– Vitafoods Europe has started, and we are excited to meet with present and potential partners in person for the first time after the pandemic. I’m looking forward to introducing aXivite and the documented benefits of our commercially ready product to this very competent and professional group of people, says Lucas Altepost, Vice President and VP Sales and Marketing at aXichem.
About aXivite and the clinical trial “Effects of Phenyl-Capsaicin on Weight Loss and Body Composition”:
aXivite (phenylcapsaicin) is a novel functional ingredient derived from the natural compound, capsaicin. In a recently completed healthy human, blinded, randomized, clinical study, aXivite demonstrated statistically significant body fat loss, an improved body-shape and lean mass profile and improved gut health, as measured by a decrease in serum zonulin. At both the low and high dose tested, aXivite showed excellent tolerability and safety profile over the 8 week treatment period.
The eight-week study was conducted as a randomized, double-blind, parallel-group clinical trial of male and female subjects recruited at a single investigational center in Northeast Ohio. The study was conducted following ICH-GCP guidelines to ensure subject safety and scientific integrity of the data. 39 patients completed the study - 12 placebo treated, 15 high dose (1,12 mg/day) aXivite treated and 12 low dose (0,560 mg/day) aXivite treated.
Read more on aXichem’s website under Scientific reports. https://www.axichem.com/science-and-rd/#scientific-reports
About Vitafoods Europe:
Vitafoods Europe started 1997 to meet the growing demands of the emerging nutraceutical industry. CEO and Founder, Nick Hawker, believed there was a need for a dedicated exhibition and scientific conference to fill a gap in the market at the time. 2019 edition of Vitafoods Europe welcomed more than 1,250 exhibitors in 23,000 square meters of floor space and gathered over 25,000 visitors in the Palexpo Exhibition Hall. This annual gathering sees a global audience across four sectors covering the entire nutraceutical supply chain, from beginning to end.
This press release was submitted by the contact person below on 4 October 2021, at 09:00 AM CET.
Company contact:
Torsten Helsing, CEO, aXichem, Ph+46 46-780 06 73. Email: torsten.helsing@axichem.se
Torsten Helsing, VD i aXichem, 046-780 06 73. E-post: torsten.helsing@axichem.se
aXichem’s business idea is to develop, patent and market natural analogue industrial compounds. The Company primarily works with phenylcapsaicin a structural analogue of capsaicin with a wide range of applications, such as feed additives, marine anti-fouling products and certain pharmaceutical areas. aXichem’s shares are listed on NASDAQ First North Growth Market under AXIC A. Certified Adviser: Redeye AB Certifiedadviser@redeye.se +46 (0)8 121 576 90. Read more about the company at www.axichem.se